Your browser doesn't support javascript.
loading
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
Lizak, Nathaniel; Lugaresi, Alessandra; Alroughani, Raed; Lechner-Scott, Jeannette; Slee, Mark; Havrdova, Eva; Horakova, Dana; Trojano, Maria; Izquierdo, Guillermo; Duquette, Pierre; Girard, Marc; Prat, Alexandre; Grammond, Pierre; Hupperts, Raymond; Grand'Maison, Francois; Sola, Patrizia; Pucci, Eugenio; Bergamaschi, Roberto; Oreja-Guevara, Celia; Van Pesch, Vincent; Ramo, Cristina; Spitaleri, Daniele; Iuliano, Gerardo; Boz, Cavit; Granella, Franco; Olascoaga, Javier; Verheul, Freek; Rozsa, Csilla; Cristiano, Edgardo; Flechter, Shlomo; Hodgkinson, Suzanne; Amato, Maria Pia; Deri, Norma; Jokubaitis, Vilija; Spelman, Tim; Butzkueven, Helmut; Kalincik, Tomas.
Afiliação
  • Lizak N; Department of Medicine, University of Melbourne, Melbourne, Australia.
  • Lugaresi A; Monash School of Medicine, Monash University, Melbourne, Australia.
  • Alroughani R; Department of Biomedical and Neuromotor Sciences, University of Bologna and IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Lechner-Scott J; Department of Neurology, Amiri Hospital, Kuwait City, Kuwait.
  • Slee M; Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.
  • Havrdova E; Flinders University and Medical Centre, Adelaide, Australia.
  • Horakova D; 1st Faculty of Medicine, Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Praha, Czech Republic.
  • Trojano M; 1st Faculty of Medicine, Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Praha, Czech Republic.
  • Izquierdo G; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
  • Duquette P; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Girard M; Hôpital Notre Dame, Montreal, Canada.
  • Prat A; Hôpital Notre Dame, Montreal, Canada.
  • Grammond P; Hôpital Notre Dame, Montreal, Canada.
  • Hupperts R; Hotel-Dieu de Levis, Quebec, Canada.
  • Grand'Maison F; Zuyderland Ziekenhuis, Sittard, The Netherlands.
  • Sola P; Neuro Rive-Sud, Hôpital Charles LeMoyne, Quebec, Canada.
  • Pucci E; Neurology Unit, Department of Neuroscience, Nuovo Ospedale Civile Sant'Agostino/Estense, Modena, Italy.
  • Bergamaschi R; Neurology Unit, ASUR Marche-AV 3, Macerata, Italy.
  • Oreja-Guevara C; C. Mondino National Neurological Institute, Pavia, Italy.
  • Van Pesch V; University Hospital San Carlos, IdISSC, Madrid, Spain.
  • Ramo C; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Spitaleri D; Hospital Germans Trias i Pujol, Badalona, Spain.
  • Iuliano G; AORN San Giuseppe Moscati, Avellino, Italy.
  • Boz C; Ospedali Riuniti di Salerno, Salerno, Italy.
  • Granella F; Karadeniz Technical University, Trabzon, Turkey.
  • Olascoaga J; University of Parma, Parma, Italy.
  • Verheul F; Department of Neurology, Donostia University Hospital, San Sebastian, Spain.
  • Rozsa C; Groen Hart Ziekenhuis, Gouda, The Netherlands.
  • Cristiano E; Jahn Ferenc Teaching Hospital, Budapest, Hungary.
  • Flechter S; Hospital Italiano, Buenos Aires, Argentina.
  • Hodgkinson S; Assaf Harofeh Medical Center, Beer-Yaakov, Israel.
  • Amato MP; Liverpool Hospital, Sydney, Australia.
  • Deri N; Section of Neurosciences, Department NEUROFARBA, University of Florence, Florence, Italy.
  • Jokubaitis V; Hospital Fernàndez, Buenos Aires, Argentina.
  • Spelman T; Department of Medicine, University of Melbourne, Melbourne, Australia.
  • Butzkueven H; Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
  • Kalincik T; Department of Medicine, University of Melbourne, Melbourne, Australia.
J Neurol Neurosurg Psychiatry ; 88(3): 196-203, 2017 Mar.
Article em En | MEDLINE | ID: mdl-27683916

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pessoas com Deficiência / Progressão da Doença / Esclerose Múltipla Recidivante-Remitente / Imunomodulação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pessoas com Deficiência / Progressão da Doença / Esclerose Múltipla Recidivante-Remitente / Imunomodulação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article